BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Favaloro EJ. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia. Int J Lab Hematol 2021;43:559-70. [PMID: 34138513 DOI: 10.1111/ijlh.13629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Smock KJ, Gosselin RC. Preface: Laboratory Diagnostics for Thrombosis and Hemostasis Testing - Part I. Semin Thromb Hemost 2022. [PMID: 36055260 DOI: 10.1055/s-0042-1755367] [Reference Citation Analysis]
2 Stoll SE, Werner P, Wetsch WA, Dusse F, Bunck AC, Kochanek M, Popp F, Schmidt T, Bruns C, Böttiger BW. Transjugular intrahepatic portosystemic shunt, local thrombaspiration, and lysis for management of fulminant portomesenteric thrombosis and atraumatic splenic rupture due to vector-vaccine-induced thrombotic thrombocytopenia: a case report. J Med Case Rep 2022;16:271. [PMID: 35821156 DOI: 10.1186/s13256-022-03464-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Thachil J, Favaloro EJ, Lippi G. D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, Including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19. Semin Thromb Hemost 2022. [PMID: 35803265 DOI: 10.1055/s-0042-1748193] [Reference Citation Analysis]
4 Said KB, Al-otaibi A, Aljaloud L, Al-anazi B, Alsolami A, Alreshidi FS; on behalf of the Ha’il COM Research Unit Group. The Frequency and Patterns of Post-COVID-19 Vaccination Syndrome Reveal Initially Mild and Potentially Immunocytopenic Signs in Primarily Young Saudi Women. Vaccines 2022;10:1015. [DOI: 10.3390/vaccines10071015] [Reference Citation Analysis]
5 Ribeiro MI, Pimenta I, Conde I, Gonzalez FA. Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination. BMJ Case Rep 2022;15:e247346. [PMID: 35589271 DOI: 10.1136/bcr-2021-247346] [Reference Citation Analysis]
6 Elsawi HA, Elborollosy A. Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis. Egypt J Intern Med 2022;34. [DOI: 10.1186/s43162-022-00129-5] [Reference Citation Analysis]
7 Ornelas-aguirre JM, Gómez-alcalá AV, Ramírez-leyva DH. Increment of D-dimer Associated with Immune Thrombotic Thrombocytopenia in ChAdOx1 nCoV-19 (AstraZeneca-Oxford) Vaccinated Individuals: A Systematic Review. Archives of Medical Research 2022. [DOI: 10.1016/j.arcmed.2022.03.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dix C, McFadyen J, Huang A, Chunilal S, Chen V, Tran H. Understanding vaccine-induced thrombotic thrombocytopenia (VITT). Intern Med J 2022. [PMID: 35446471 DOI: 10.1111/imj.15783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yamada S, Asakura H. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. IJMS 2022;23:3338. [DOI: 10.3390/ijms23063338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 John CV, Kumar R, Sivan AK, Jithin S, Abraham R, Philip CC. Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India. Thromb J 2022;20:11. [PMID: 35246163 DOI: 10.1186/s12959-022-00370-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Abrignani MG, Murrone A, De Luca L, Roncon L, Di Lenarda A, Valente S, Caldarola P, Riccio C, Oliva F, Gulizia MM, Gabrielli D, Colivicchi F, On Behalf Of The Working Group On Anti-Covid-Vaccination Of The Associazione Nazionale Medici Cardiologi Ospedalieri Anmco. COVID-19, Vaccines, and Thrombotic Events: A Narrative Review. J Clin Med 2022;11:948. [PMID: 35207220 DOI: 10.3390/jcm11040948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
12 Favaloro EJ, Pasalic L, Henry B, Lippi G. Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia. Pathology 2022:S0031-3025(21)00831-X. [PMID: 35125202 DOI: 10.1016/j.pathol.2021.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Favaloro EJ, Lippi G. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part III. Semin Thromb Hemost 2022;48:3-7. [PMID: 35104908 DOI: 10.1055/s-0041-1736169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hsiao P, Wu K, Chen Y, Chen Y, Wang R, Wu K, Chan J, Chiu C, Huang L, Shyu H, Kao Y, Chuu C. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Comparison of the manifestation, laboratory diagnosis, and management in clinical scenario. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Favaloro EJ, Pasalic L, Lippi G. Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT). Clin Chem Lab Med 2022;60:7-17. [PMID: 34714985 DOI: 10.1515/cclm-2021-1039] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
16 Favaloro EJ, Pasalic L, Lippi G. Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS. Antibodies 2022;11:7. [DOI: 10.3390/antib11010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Choi H, Lee SM, Lim S, Shin KH, Kim T, Kim WJ, Yun M, Oh SH. Immunogenicity after Second ChAdOx1 nCoV-19 (AZD1222) Vaccination According to the Individual Reactogenicity, Health Status and Lifestyle. Vaccines (Basel) 2021;9:1473. [PMID: 34960219 DOI: 10.3390/vaccines9121473] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Zdanyte M, Rath D, Gawaz M, Geisler T. Venous Thrombosis and SARS-CoV-2. Hamostaseologie 2021. [PMID: 34879422 DOI: 10.1055/a-1661-0283] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Barefah AS, Radhwi OO, Alamri SS, Alahwal HM, Denetiu I, Almohammadi AT, Bahashwan SM, Qari MH, Algaissi A, Alamer E, Alhazmi A, Abuzenadah AM, Nasraldeen WH, Alzahrani SH, Hashem AM. Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine. Int J Lab Hematol 2021. [PMID: 34850575 DOI: 10.1111/ijlh.13774] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
20 Klok FA, Pai M, Huisman MV, Makris M. Vaccine-induced immune thrombotic thrombocytopenia. Lancet Haematol 2021:S2352-3026(21)00306-9. [PMID: 34774202 DOI: 10.1016/S2352-3026(21)00306-9] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
21 Gunasekera L, Wijeratne T. Vaccine Hesitancy during the Coronavirus Pandemic-Lessons from Polio. Life (Basel) 2021;11:1207. [PMID: 34833083 DOI: 10.3390/life11111207] [Reference Citation Analysis]
22 Chang JC, Hawley HB. Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina (Kaunas) 2021;57:1163. [PMID: 34833382 DOI: 10.3390/medicina57111163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Lippi G, Favaloro EJ. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More. Semin Thromb Hemost 2021. [PMID: 34695859 DOI: 10.1055/s-0041-1736168] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
24 Root-Bernstein R. COVID-19 coagulopathies: Human blood proteins mimic SARS-CoV-2 virus, vaccine proteins and bacterial co-infections inducing autoimmunity: Combinations of bacteria and SARS-CoV-2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin-binding proteins, platelet factor 4, prothrombin, and coagulation factors. Bioessays 2021;43:e2100158. [PMID: 34677872 DOI: 10.1002/bies.202100158] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
25 Warkentin TE, Pai M. Editorial on Thaler et al. long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia. Thromb Res 2021 in press. Thromb Res 2021;207:158-60. [PMID: 34757250 DOI: 10.1016/j.thromres.2021.10.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
27 Major A, Carll T, Chan CW, Christenson C, Aldarweesh F, Wool GD, Cohen KS. Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). J Clin Apher 2021. [PMID: 34672380 DOI: 10.1002/jca.21945] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
28 Thachil J. COVID-19 Vaccine-Induced Immune Thrombosis with Thrombocytopenia (VITT) and the Shades of Grey in Thrombus Formation. Semin Thromb Hemost 2021. [PMID: 34624910 DOI: 10.1055/s-0041-1735453] [Reference Citation Analysis]
29 Schneider J, Sottmann L, Greinacher A, Hagen M, Kasper HU, Kuhnen C, Schlepper S, Schmidt S, Schulz R, Thiele T, Thomas C, Schmeling A. Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. Int J Legal Med 2021;135:2335-45. [PMID: 34591186 DOI: 10.1007/s00414-021-02706-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
30 Di Micco P, Camporese G, Cardillo G, Lodigiani C, Carannante N, Annunziata A, Fiorentino G, Russo V, Imbalzano E. Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency. Medicina (Kaunas) 2021;57:997. [PMID: 34684034 DOI: 10.3390/medicina57100997] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
31 Rizk JG, Gupta A, Sardar P, Henry BM, Lewin JC, Lippi G, Lavie CJ. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol 2021. [PMID: 34374713 DOI: 10.1001/jamacardio.2021.3444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 33] [Article Influence: 1.0] [Reference Citation Analysis]
32 Passariello M, Vetrei C, Amato F, De Lorenzo C. Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis. Int J Mol Sci 2021;22:8562. [PMID: 34445266 DOI: 10.3390/ijms22168562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]